|
|
|
|
pmid:
|
Taylor WR et al. |
Malaria prophylaxis using azithromycin: a double-blind, placebo-controlled trial in Irian Jaya, Indonesia. |
1999 |
Clin. Infect. Dis. |
pmid:10028075
|
Uy HS et al. |
Infectious crystalline keratopathy and endophthalmitis secondary to Mycobacterium abscessus in a monocular patient with Stevens-Johnson syndrome. |
1999 |
Am. J. Ophthalmol. |
pmid:10030567
|
Bizjak ED et al. |
Intravenous azithromycin-induced ototoxicity. |
1999 |
Pharmacotherapy |
pmid:10030778
|
Wubbel L et al. |
Etiology and treatment of community-acquired pneumonia in ambulatory children. |
1999 |
Pediatr. Infect. Dis. J. |
pmid:10048679
|
O'Doherty B and Muller O |
Randomized, multicentre study of the efficacy and tolerance of azithromycin versus clarithromycin in the treatment of adults with mild to moderate community-acquired pneumonia. Azithromycin Study Group. |
1998 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:10052544
|
Ogasawara KK and Goodwin TM |
Efficacy of azithromycin in reducing lower genital Ureaplasma urealyticum colonization in women at risk for preterm delivery. |
1999 Jan-Feb |
J Matern Fetal Med |
pmid:10052839
|
Van Bambeke F et al. |
Lysosomal alterations induced in cultured rat fibroblasts by long-term exposure to low concentrations of azithromycin. |
1998 |
J. Antimicrob. Chemother. |
pmid:10052900
|
Wyrick PB et al. |
Persistent chlamydial envelope antigens in antibiotic-exposed infected cells trigger neutrophil chemotaxis. |
1999 |
J. Infect. Dis. |
pmid:10068592
|
Shirtliff ME et al. |
Oral rifampin plus azithromycin or clarithromycin to treat osteomyelitis in rabbits. |
1999 |
Clin. Orthop. Relat. Res. |
pmid:10078148
|
Stamm WE |
Chlamydia trachomatis infections: progress and problems. |
1999 |
J. Infect. Dis. |
pmid:10081511
|
Garey KW and Amsden GW |
Intravenous azithromycin. |
1999 |
Ann Pharmacother |
pmid:10084418
|
Ong EL |
Prophylaxis against disseminated Mycobacterium avium complex in AIDS. |
1999 |
J. Infect. |
pmid:10090497
|
Anderson JL et al. |
Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamydia (ACADEMIC) study. |
1999 |
Circulation |
pmid:10096928
|
Aubert JD et al. |
Function of human alveolar macrophages after a 3-day course of azithromycin in healthy volunteers. |
1998 |
Pulm Pharmacol Ther |
pmid:10101742
|
Breitschwerdt EB et al. |
Efficacy of doxycycline, azithromycin, or trovafloxacin for treatment of experimental Rocky Mountain spotted fever in dogs. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10103185
|
Lea AP and Lamb HM |
Azithromycin. A pharmacoeconomic review of its use as a single-dose regimen in the treatment of uncomplicated urogenital Chlamydia trachomatis infections in women. |
1997 |
Pharmacoeconomics |
pmid:10174326
|
Montenez JP et al. |
Interactions of macrolide antibiotics (Erythromycin A, roxithromycin, erythromycylamine [Dirithromycin], and azithromycin) with phospholipids: computer-aided conformational analysis and studies on acellular and cell culture models. |
1999 |
Toxicol. Appl. Pharmacol. |
pmid:10198278
|
Laine L et al. |
Once-daily therapy for H. pylori infection: a randomized comparison of four regimens. |
1999 |
Am. J. Gastroenterol. |
pmid:10201465
|
Borisov I |
[A new therapeutic approach in the treatment of genital chlamydial infections. Azithromycin (Sumamed)]. |
1998 |
Akush Ginekol (Sofiia) |
pmid:10204275
|
Amsden GW |
Pharmacological considerations in the emergence of resistance. |
1999 |
Int. J. Antimicrob. Agents |
pmid:10204634
|
Retsema JA |
Susceptibility and resistance emergence studies with macrolides. |
1999 |
Int. J. Antimicrob. Agents |
pmid:10204635
|
Scaglione F et al. |
Interpretation of middle ear fluid concentrations of antibiotics: comparison between ceftibuten, cefixime and azithromycin. |
1999 |
Br J Clin Pharmacol |
pmid:10215750
|
Khan AA et al. |
Effect of clarithromycin and azithromycin on production of cytokines by human monocytes. |
1999 |
Int. J. Antimicrob. Agents |
pmid:10221415
|
Garey KW et al. |
Lack of effect of zafirlukast on the pharmacokinetics of azithromycin, clarithromycin, and 14-hydroxyclarithromycin in healthy volunteers. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10223928
|
Ouadrhiri Y et al. |
Mechanism of the intracellular killing and modulation of antibiotic susceptibility of Listeria monocytogenes in THP-1 macrophages activated by gamma interferon. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10223943
|
Könönen E et al. |
beta-lactamase production and antimicrobial susceptibility of oral heterogeneous Fusobacterium nucleatum populations in young children. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10223950
|
Bergman KL et al. |
Antimicrobial activities and postantibiotic effects of clarithromycin, 14-hydroxy-clarithromycin, and azithromycin in epithelial cell lining fluid against clinical isolates of haemophilus influenzae and Streptococcus pneumoniae. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10223956
|
Akova M et al. |
In vitro activities of antibiotics alone and in combination against Brucella melitensis at neutral and acidic pHs. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10223958
|
Gorenek L et al. |
The diagnosis and treatment of Clostridium difficile in antibiotic-associated diarrhea. |
1999 Jan-Feb |
Hepatogastroenterology |
pmid:10228818
|
Taylor H |
Towards the global elimination of trachoma. |
1999 |
Nat. Med. |
pmid:10229224
|
Lietman T et al. |
Global elimination of trachoma: how frequently should we administer mass chemotherapy? |
1999 |
Nat. Med. |
pmid:10229236
|
Nowicki M et al. |
Partial regression of advanced cyclosporin-induced gingival hyperplasia after treatment with azithromycin. A case report. |
1998 |
Ann. Transplant. |
pmid:10234432
|
Carbon C and Poole MD |
The role of newer macrolides in the treatment of community-acquired respiratory tract infection. A review of experimental and clinical data. |
1999 |
J Chemother |
pmid:10326741
|
Cazzola M et al. |
Comparative study of dirithromycin and azithromycin in the treatment of acute bacterial exacerbations of chronic bronchitis. |
1999 |
J Chemother |
pmid:10326742
|
Petitta A et al. |
Economic evaluation of three methods of treating urogenital chlamydial infections in the emergency department. |
1999 |
Pharmacotherapy |
pmid:10331829
|
Cammarota G et al. |
Three-day antibiotic therapy with azithromycin and tinidazole plus lansoprazole or pantoprazole to cure Helicobacter pylori infection: a pilot study. |
1999 |
Eur J Gastroenterol Hepatol |
pmid:10333196
|
Wirnsberger GH and Pfragner R |
Comment on "Efficacy of azithromycin in the treatment of cyclosporine-induced gingival hyperplasia in renal transplant recipients" by Nash and Zaltzman. |
1999 |
Transplantation |
pmid:10342326
|
Girgis NI et al. |
Azithromycin versus ciprofloxacin for treatment of uncomplicated typhoid fever in a randomized trial in Egypt that included patients with multidrug resistance. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10348767
|
Wolf K and Malinverni R |
Effect of azithromycin plus rifampin versus that of azithromycin alone on the eradication of Chlamydia pneumoniae from lung tissue in experimental pneumonitis. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10348778
|
Ngo LY et al. |
Pharmacokinetics of azithromycin administered alone and with atovaquone in human immunodeficiency virus-infected children. The ACTG 254 Team. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10348786
|
Vcev A et al. |
High dose omeprazole plus amoxicillin and azithromycin in eradication of Helicobacter pylori in duodenal ulcers. |
1999 |
Helicobacter |
pmid:10352088
|
Cinti S et al. |
Killing of Mycobacterium avium by neutrophils and monocytes from AIDS patients treated with recombinant granulocyte-macrophage colony-stimulating factor. |
1999 |
J. Infect. Dis. |
pmid:10353887
|
Walterspiel JN |
Treatment of cat scratch disease. |
1999 |
N. Engl. J. Med. |
pmid:10366328
|
Johnson JR |
Therapy for Legionnaires disease. |
1999 |
Ann. Intern. Med. |
pmid:10366385
|
Preheim LC et al. |
Ethanol feeding does not affect the efficacy or pharmacokinetics of azithromycin, trovafloxacin, or ceftriaxone in a rat model of pneumococcal pneumonia. |
1999 |
Alcohol. Clin. Exp. Res. |
pmid:10371404
|
Dimitrakov J et al. |
A case of Chlamydia trachomatis infection in a renal allograft patient. |
1998 |
Folia Med (Plovdiv) |
pmid:10371799
|
Alvarez-Elcoro S and Enzler MJ |
The macrolides: erythromycin, clarithromycin, and azithromycin. |
1999 |
Mayo Clin. Proc. |
pmid:10377939
|
Schönwald S et al. |
Azithromycin: single 1.5 g dose in the treatment of patients with atypical pneumonia syndrome--a randomized study. |
1999 May-Jun |
Infection |
pmid:10378132
|
Lombardo L et al. |
Helicobacter pylori eradication using one-week low-dose lansoprazole plus amoxycillin and azithromycin: failure of a "promising" association. |
1999 |
Ital J Gastroenterol Hepatol |
pmid:10379493
|
Trautmann M et al. |
Combined activity of azithromycin and lansoprazole against Helicobacter pylori. |
1999 |
Helicobacter |
pmid:10382125
|
Steele-Moore L et al. |
In vitro activities of clarithromycin and azithromycin against clinical isolates of Mycobacterium avium-M. intracellulare. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10383373
|
Baće A et al. |
Short-term treatment of pertussis with azithromycin in infants and young children. |
1999 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:10385021
|
Taylor KI and Taylor HR |
Distribution of azithromycin for the treatment of trachoma. |
1999 |
Br J Ophthalmol |
pmid:10396186
|
de Vries PI et al. |
Short course of azithromycin/artesunate against falciparum malaria: no full protection against recrudescence. |
1999 |
Trop. Med. Int. Health |
pmid:10402979
|
Horgan SE et al. |
Use of a low nutrient culture medium for the identification of bacteria causing severe ocular infection. |
1999 |
J. Med. Microbiol. |
pmid:10403423
|
Donati M et al. |
Comparative in-vitro activity of moxifloxacin, minocycline and azithromycin against Chlamydia spp. |
1999 |
J. Antimicrob. Chemother. |
pmid:10404322
|
Neiger R et al. |
Use of a urea breath test to evaluate short-term treatments for cats naturally infected with Helicobacter heilmannii. |
1999 |
Am. J. Vet. Res. |
pmid:10407483
|
Sawhney N |
MAC prophylaxis in the era of polypharmacy. |
1999 May-Jun |
WMJ |
pmid:10414219
|
Foster DR and Milan NL |
Potential interaction between azithromycin and warfarin. |
1999 |
Pharmacotherapy |
pmid:10417043
|
Johnson MM et al. |
Effect of carbon dioxide on testing of susceptibilities of respiratory tract pathogens to macrolide and azalide antimicrobial agents. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10428903
|
Credito KL et al. |
Activity of telithromycin (HMR 3647) against anaerobic bacteria compared to those of eight other agents by time-kill methodology. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10428930
|
Foulds G et al. |
The effect of azithromycin on the pharmacokinetics of indinavir. |
1999 |
J Clin Pharmacol |
pmid:10434237
|
Umut S et al. |
Determination of the etiological organism during acute exacerbations of COPD and efficacy of azithromycin, ampicillin-sulbactam, ciprofloxacin and cefaclor. Turkish Thoracic Society COPD Working Group. |
1999 |
J Chemother |
pmid:10435684
|
Krichhoff RM et al. |
Determination of azithromycin in gastric biopsy samples. |
1999 |
Int J Clin Pharmacol Ther |
pmid:10442511
|
Pasternack R et al. |
Follow up of treatment: an integral part of the control of Chlamydia trachomatis infections. |
1999 |
Sex Transm Infect |
pmid:10448353
|
Kamath R |
Antibiotic therapy for Salmonella enteritis. |
1999 |
J Paediatr Child Health |
pmid:10457286
|
Chiu CH et al. |
A clinical trial comparing oral azithromycin, cefixime and no antibiotics in the treatment of acute uncomplicated Salmonella enteritis in children. |
1999 |
J Paediatr Child Health |
pmid:10457295
|
Sendi PP et al. |
Systematic validation of disease models for pharmacoeconomic evaluations. Swiss HIV Cohort Study. |
1999 |
J Eval Clin Pract |
pmid:10461580
|
Schachter J et al. |
Azithromycin in control of trachoma. |
1999 |
Lancet |
pmid:10466664
|
Kutlin A et al. |
In vitro activities of azithromycin and ofloxacin against Chlamydia pneumoniae in a continuous-infection model. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10471577
|
Bui KQ et al. |
Mononuclear and polymorphonuclear leukocyte dispositions of clarithromycin and azithromycin in AIDS patients requiring Mycobacterium avium complex prophylaxis. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10471584
|
Alvarez Gutiérrez FJ et al. |
[A randomized comparative study of 3 days of azithromycin treatment and 10 days of cefuroxime treatment in exacerbations in patients with chronic obstructive pulmonary disease]. |
1999 |
Med Clin (Barc) |
pmid:10472596
|
Butler T et al. |
Treatment of typhoid fever with azithromycin versus chloramphenicol in a randomized multicentre trial in India. |
1999 |
J. Antimicrob. Chemother. |
pmid:10473232
|
Howard KB et al. |
Azithromycin versus erythromycin for community-acquired pneumonia: a cost-minimization analysis. |
1999 |
Am J Health Syst Pharm |
pmid:10478989
|
Dunne MW et al. |
Efficacy of azithromycin in prevention of Pneumocystis carinii pneumonia: a randomised trial. California Collaborative Treatment Group. |
1999 |
Lancet |
pmid:10489947
|
Moore PA |
Dental therapeutic indications for the newer long-acting macrolide antibiotics. |
1999 |
J Am Dent Assoc |
pmid:10492541
|
Braz LM et al. |
[The evaluation of the efficacy of azithromycin and pyrimethamine used alone or in combination in the treatment of an experimental infection in mice by Toxoplasma gondii]. |
1999 Jul-Aug |
Rev. Soc. Bras. Med. Trop. |
pmid:10495670
|
Hook EW et al. |
Azithromycin compared with penicillin G benzathine for treatment of incubating syphilis. |
1999 |
Ann. Intern. Med. |
pmid:10498560
|
Blandizzi C et al. |
Periodontal tissue disposition of azithromycin in patients affected by chronic inflammatory periodontal diseases. |
1999 |
J. Periodontol. |
pmid:10505797
|
Zarantonelli L et al. |
Decreased azithromycin susceptibility of Neisseria gonorrhoeae due to mtrR mutations. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10508026
|
Jackson LA et al. |
Safety and effect on anti-Chlamydia pneumoniae antibody titres of a 1 month course of daily azithromycin in adults with coronary artery disease. |
1999 |
J. Antimicrob. Chemother. |
pmid:10511413
|
Yoh M et al. |
Effect of subinhibitory concentrations of antimicrobial agents (quinolones and macrolide) on the production of verotoxin by enterohemorrhagic Escherichia coli O157:H7. |
1999 |
Can. J. Microbiol. |
pmid:10526400
|
Melnichouk S et al. |
Evaluation of lansoprazole (an H+/K+-ATPase inhibitor) and azithromycin (an antibiotic) for control of gastric ulceration in swine during periods of feed deprivation. |
1999 |
Can. J. Vet. Res. |
pmid:10534003
|
Howell MR et al. |
Control of Chlamydia trachomatis infections in female army recruits: cost-effective screening and treatment in training cohorts to prevent pelvic inflammatory disease. |
1999 |
Sex Transm Dis |
pmid:10534206
|
Mabey D and Bailey R |
Eradication of trachoma worldwide. |
1999 |
Br J Ophthalmol |
pmid:10535853
|
Muhlestein JB |
Animal models of chlamydia and atherosclerosis. |
1999 |
Am. Heart J. |
pmid:10539862
|
Gupta S |
Chlamydia pneumoniae, monocyte activation, and azithromycin in coronary heart disease. |
1999 |
Am. Heart J. |
pmid:10539869
|
Dunne M |
WIZARD and the design of trials for secondary prevention of atherosclerosis with antibiotics. |
1999 |
Am. Heart J. |
pmid:10539870
|
Grayston JT |
Design of future intervention studies for Chlamydia pneumoniae in atherosclerosis. |
1999 |
Am. Heart J. |
pmid:10539875
|
Goldstein EJ et al. |
Activities of telithromycin (HMR 3647, RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and other antimicrobial agents against unusual anaerobes. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10543769
|
Watt G et al. |
Azithromycin activities against Orientia tsutsugamushi strains isolated in cases of scrub typhus in Northern Thailand. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10543774
|
Ghaffar F et al. |
Increased carriage of resistant non-pneumococcal alpha-hemolytic streptococci after antibiotic therapy. |
1999 |
J. Pediatr. |
pmid:10547251
|
Fong IW et al. |
Can an antibiotic (macrolide) prevent Chlamydia pneumoniae-induced atherosclerosis in a rabbit model? |
1999 |
Clin. Diagn. Lab. Immunol. |
pmid:10548582
|
|
[Short-term therapy with Azithromycin. Pneumonia-pathogens, most commonly encountered in practice, easily targeted]. |
1999 |
Internist (Berl) |
pmid:10549000
|
Whitty CJ et al. |
Impact of community-based mass treatment for trachoma with oral azithromycin on general morbidity in Gambian children. |
1999 |
Pediatr. Infect. Dis. J. |
pmid:10571428
|
Tan HH and Chan RK |
An open label comparative study of azithromycin and doxycycline in the treatment of non-gonococcal urethritis in males and Chlamydia trachomatis cervicitis in female sex workers in an STD clinic in Singapore. |
1999 |
Singapore Med J |
pmid:10572491
|
Chern KC et al. |
Alterations in the conjunctival bacterial flora following a single dose of azithromycin in a trachoma endemic area. |
1999 |
Br J Ophthalmol |
pmid:10574809
|
Paavonen J and Eggert-Kruse W |
Chlamydia trachomatis: impact on human reproduction. |
1999 Sep-Oct |
Hum. Reprod. Update |
pmid:10582782
|
Koletar SL et al. |
Azithromycin as treatment for disseminated Mycobacterium avium complex in AIDS patients. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10582873
|